Status:
COMPLETED
Abnormalities of B Lymphocytes During Systemic Lupus
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Previous experimental data strongly suggest that B lymphocytes have intrinsic abnormalities during lupus in mice spontaneously affected by the disease. This study tries to define these abnormalities b...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- non active systemic lupus
- Exclusion criteria:
- immunosuppressive drugs
- more than 10 mg of prednisone per day
Exclusion
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00401141
Start Date
April 1 2004
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'Immunologie Clinique et VIH - Hôpital Civil
Strasbourg, France, 67091